Immediate Impact
3 from Science/Nature 61 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Works of P. Pearson being referenced
545P Preclinical profile of EPI-7386, a second-generation N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer
2020
The preclinical characterization of the N-terminal domain androgen receptor inhibitor, EPI-7386, for the treatment of prostate cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P. Pearson | 52 | 22 | 46 | 26 | 17 | 177 | |
| Behzad M. Toosi | 53 | 11 | 84 | 44 | 25 | 236 | |
| Yintong Xue | 48 | 10 | 73 | 17 | 12 | 278 | |
| Ayako Hayashi | 27 | 3 | 46 | 11 | 26 | 255 | |
| Hiroaki Nagatomo | 49 | 17 | 135 | 7 | 19 | 276 | |
| A Demoulin | 15 | 21 | 45 | 17 | 21 | 287 | |
| Ada Watson | 71 | 3 | 85 | 12 | 13 | 273 | |
| R Wyss | 80 | 8 | 91 | 13 | 12 | 269 | |
| Stephan Jansen | 25 | 5 | 42 | 8 | 13 | 183 | |
| Julia Werner | 37 | 27 | 43 | 13 | 22 | 186 | |
| Yisheng Lu | 22 | 11 | 82 | 8 | 17 | 293 |
All Works
Loading papers...